Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2011. Start Trial.
Date Value
November 13, 2026 -155.09M
November 12, 2026 -177.19M
November 11, 2026 -180.50M
November 10, 2026 -171.82M
November 09, 2026 -160.30M
November 06, 2026 -183.27M
November 05, 2026 -188.63M
November 04, 2026 -191.16M
November 03, 2026 -193.21M
November 02, 2026 -193.57M
October 30, 2026 -193.53M
October 29, 2026 -189.58M
October 28, 2026 -190.76M
October 27, 2026 -191.12M
October 26, 2026 -197.47M
October 23, 2026 -195.26M
October 22, 2026 -183.42M
October 21, 2026 -177.74M
October 20, 2026 -182.75M
October 19, 2026 -180.39M
October 16, 2026 -186.03M
October 15, 2026 -174.43M
October 14, 2026 -184.84M
October 13, 2026 -174.23M
October 12, 2026 -174.66M
Date Value
October 09, 2026 -162.19M
October 08, 2026 -169.73M
October 07, 2026 -166.41M
October 06, 2026 -149.32M
October 05, 2026 -133.14M
October 02, 2026 -140.37M
October 01, 2026 -146.84M
September 30, 2026 -141.98M
September 29, 2026 -168.93M
September 28, 2026 -163.44M
September 25, 2026 -158.50M
September 24, 2026 -157.29M
September 23, 2026 -157.68M
September 22, 2026 -154.62M
September 21, 2026 -157.72M
September 18, 2026 -146.78M
September 17, 2026 -162.38M
September 16, 2026 -170.58M
September 15, 2026 -177.95M
September 14, 2026 -175.52M
September 11, 2026 -178.07M
September 10, 2026 -178.19M
September 09, 2026 -163.56M
September 08, 2026 -177.28M
September 04, 2026 -179.83M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Agilent Technologies, Inc. 51.24B
Bio-Rad Laboratories, Inc. 9.549B
Bruker Corp. 11.01B
Danaher Corp. 186.02B
Harvard Bioscience, Inc. 82.38M